Technology
What is Photodisinfection?
Photodisinfection delivers fast, broad spectrum microbial kill in minutes via a specific combination of factors:
Photodisinfection destroys bacteria, viruses and fungus without harming human cells or causing antimicrobial resistance.
Non-Resistance Forming
The external destruction of the microbe is so rapid, and so extensive, that the internal genome does not have the opportunity to mutate, or otherwise alter microbial defenses, to combat the oxidative stress.
By eliminating concerns about microbial resistance, our photodisinfection technology can be applied in a broad range of use cases (chronic diseases, high-risk patients, healthcare workers) and is appropriate for repeat use, leading to better outcomes for patients, and greater cost savings for hospitals as well as healthcare systems.
Our products
A rapid nasal decolonization therapy that eradicates a broad spectrum of pathogens in the nose in only minutes. Steriwave enables rapid elimination of pathogens associated with healthcare-associated infections (HAIs), reduces the reliance on patient compliance and screening, and eliminates the potential generation of resistance associated with topical antibiotics and other antimicrobials.
Steriwave treatment destroys nasal pathogens (including Staphylococcus aureus, Candida auris, SARS-CoV-2, MRSA and other superbugs) significantly reducing a person’s risk of infection or passing these pathogens along to others. Over the past decade, Steriwave has helped Vancouver General Hospital to reduce its surgical site infections (SSIs) by up to 84%.
In addition to our lead product, Steriwave, we also have a number of products in development, including treatment of chronic rhinosinusitis, decolonization of burns and wounds, disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia and most recently, the development of topical antiviral therapy for the upper respiratory tract to reduce SARS-CoV-2 titre and transmission.
